Literature DB >> 5339043

Multiclinic trials in cancer chemotherapy.

C G Zubrod.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 5339043      PMCID： PMC1923131     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  IMPLICATIONS OF LONG-TERM SURVIVAL IN ACUTE STEM CELL LEUKEMIA OF CHILDHOOD TREATED WITH COMPOSITE CYCLIC THERAPY.

Authors:  W W ZUELZER
Journal:  Blood       Date:  1964-11       Impact factor: 22.113

2.  THE FEASIBILITY OF USING RANDOMIZATION SCHEMES EARLY IN THE CLINICAL TRIALS OF NEW CHEMOTHERAPEUTIC AGENTS: HYDROXYUREA (NSC-32065).

Authors:  P P CARBONE; M J KRANT; S P MILLER; T C HALL; B I SHNIDER; J COLSKY; J HORTON; H HOSLEY; J M MILLER; E FREI
Journal:  Clin Pharmacol Ther       Date:  1965 Jan-Feb       Impact factor: 6.875

3.  Predicting anticancer drug effects in man from laboratory animal studies.

Authors:  A H OWENS
Journal:  J Chronic Dis       Date:  1962-03

4.  A comparative study of two regimens of combination chemotherapy in acute leukemia.

Authors:  E FREI; J F HOLLAND; M A SCHNEIDERMAN; D PINKEL; G SELKIRK; E J FREIREICH; R T SILVER; G L GOLD; W REGELSON
Journal:  Blood       Date:  1958-12       Impact factor: 22.113

5.  Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.

Authors:  A GOLDIN; S R HUMPHREYS; N MANTEL; J M VENDITTI
Journal:  J Natl Cancer Inst       Date:  1956-08       Impact factor: 13.506

6.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

7.  What shall we measure on whom: why?

Authors:  M A Schneiderman; M J Krant
Journal:  Cancer Chemother Rep       Date:  1966-03

8.  Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors.

Authors:  W S Wilcox; D P Griswold; W R Laster; F M Schabel; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1965-08

9.  Experimental screening procedures and clinical predictability value.

Authors:  A Goldin; A A Serpick; N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-05

10.  New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.

Authors: 
Journal:  JAMA       Date:  1965-10-04       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.